Better Coronavirus Stock: BioNTech or GlaxoSmithKline?
While coronavirus cases in other developed countries are flattening, the U.S. has not been so fortunate. As of July 24, the number of coronavirus cases in the U.S. has reached a new record, with more than 78,000 Americans infected. Meanwhile, approximately 1,485 Americans are dying each day of COVID-19.
There is light at the end of the tunnel, however. Currently, two of the largest biotech companies in the world, BioNTech (NASDAQ: BNTX)and GlaxoSmithKline (NYSE: GSK), are part of the race for a COVID-19 cure. Let's take a look at which of the two companies is the better buy.
Image Source: Getty Images.
Source Fool.com
